Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19.

Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19.

Publication date: Dec 15, 2024

The clinical frailty scale (CFS) was used as a triage tool for medical decision making during the COVID-19 pandemic. The CFS has been posed as a suitable risk marker for in-hospital mortality in COVID-19 patients. We evaluated whether the CFS is associated with mortality 24 months after hospitalisation for COVID-19. The COvid MEdicaTion (COMET) study is an international, multicentre, observational cohort study, including adult patients hospitalised for COVID-19 between March 2020-July 2020. Patients’ characteristics, prescribed medication, clinical characteristics, and CFS were collected at admission, survival data were collected 24 months after hospitalisation. Multivariable cox proportional hazard models stratified by age (

Concepts Keywords
Comet COVID-19
Covid Frailty
Hospitalisation Long-term
July Survival

Semantics

Type Source Name
disease MESH Frailty
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)